Literature DB >> 4554808

[Metabolic products of microorganisms. 99. Kirromycin].

H Wolf, H Zähner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4554808

Source DB:  PubMed          Journal:  Arch Mikrobiol        ISSN： 0003-9276


× No keyword cloud information.
  7 in total

1.  ON THE BIOSYNTHESIS OF GRAMICIDIN S.

Authors:  T S EIKHOM; J JONSEN; S LALAND; T REFSVIK
Journal:  Biochim Biophys Acta       Date:  1963-11-22

2.  [METABOLIC PRODUCTS FROM MICROORGANISMS. 48. SCOPAMYCIN].

Authors:  R HUETTER; W KELLER-SCHIERLEIN; J NUEESCH; H ZAEHNER
Journal:  Arch Mikrobiol       Date:  1965-05-28

3.  Metabolism of resistant mutants of Streptococcus faecalis. IV. Use of a biophotometer in growth-curve studies.

Authors:  M K COULTAS; D J HUTCHISON
Journal:  J Bacteriol       Date:  1962-09       Impact factor: 3.490

4.  [Phage resistance of stabile L-forms of Proteus mirabilis].

Authors:  U TAUBENECK
Journal:  Z Naturforsch B       Date:  1961-12       Impact factor: 1.047

5.  Countercurrent distribution.

Authors:  T P KING; L C CRAIG
Journal:  Methods Biochem Anal       Date:  1962

6.  Susceptibility of Proteus mirabilis and its stable L-forms to erythromycin and other macrolides.

Authors:  U TAUBENECK
Journal:  Nature       Date:  1962-10-13       Impact factor: 49.962

7.  [Influence of bacteriophage on the L phase of Proteus mirabilis].

Authors:  U TAUBENECK; H BOHME
Journal:  Z Naturforsch B       Date:  1958-07       Impact factor: 1.047
  7 in total
  11 in total

Review 1.  Elfamycins: inhibitors of elongation factor-Tu.

Authors:  Samantha M Prezioso; Nicole E Brown; Joanna B Goldberg
Journal:  Mol Microbiol       Date:  2017-08-09       Impact factor: 3.501

2.  Identification and activation of novel biosynthetic gene clusters by genome mining in the kirromycin producer Streptomyces collinus Tü 365.

Authors:  Dumitrita Iftime; Andreas Kulik; Thomas Härtner; Sabrina Rohrer; Timo Horst Johannes Niedermeyer; Evi Stegmann; Tilmann Weber; Wolfgang Wohlleben
Journal:  J Ind Microbiol Biotechnol       Date:  2015-10-03       Impact factor: 3.346

3.  Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.

Authors:  H Wolf; G Chinali; A Parmeggiani
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

4.  Pulvomycin, an inhibitor of protein biosynthesis preventing ternary complex formation between elongation factor Tu, GTP, and aminoacyl-tRNA.

Authors:  H Wolf; D Assmann; E Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

5.  Mutants of Escherichia coli altered in both genes coding for the elongation factor Tu.

Authors:  J A Van de Klundert; P H Van der Meide; P Van de Putte; L Bosch
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

6.  Elongation factor Tu resistant to kirromycin in an Escherichia coli mutant altered in both tuf genes.

Authors:  E Fischer; H Wolf; K Hantke; A Parmeggiani
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

7.  Bioconversion capacity of Streptomyces sp GE44282, a producer of the antibiotics heneicomycin and aurodox.

Authors:  F Marinelli; S Stella; N Montanini; F Le Monnier; L Cavaletti; E Selva
Journal:  J Ind Microbiol       Date:  1995-07

8.  tmRNA of Streptomyces collinus and Streptomyces griseus during the growth and in the presence of antibiotics.

Authors:  Petra Palecková; Jan Bobek; Karel Mikulík
Journal:  Microb Biotechnol       Date:  2008-10-13       Impact factor: 5.813

Review 9.  tRNAs as antibiotic targets.

Authors:  Shaileja Chopra; John Reader
Journal:  Int J Mol Sci       Date:  2014-12-25       Impact factor: 5.923

10.  Filling the Gaps in the Kirromycin Biosynthesis: Deciphering the Role of Genes Involved in Ethylmalonyl-CoA Supply and Tailoring Reactions.

Authors:  Helene L Robertsen; Ewa M Musiol-Kroll; Ling Ding; Kristina J Laiple; Torben Hofeditz; Wolfgang Wohlleben; Sang Yup Lee; Stephanie Grond; Tilmann Weber
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.